Comparative toxicity of known and putative metabolites of 1,3-butadiene in human CD34+ bone marrow cells
- 18 September 2000
- journal article
- research article
- Published by Elsevier in Toxicology
- Vol. 150 (1-3) , 99-106
- https://doi.org/10.1016/s0300-483x(00)00249-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Synthetic route to optically-pure metabolites of butadiene, and their chiral GC separationTetrahedron Letters, 1996
- Species Differences in Urinary Butadiene Metabolites: Comparisons of Metabolite Ratios between Mice, Rats, and HumansToxicology and Applied Pharmacology, 1994
- Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblastsCarcinogenesis: Integrative Cancer Research, 1994
- Chemical suppression of a subpopulation of primitive hematopoietic progenitor cells: 1,3-butadiene produces a hematopoietic defect similar to steel or white spotted mutations in mice.Proceedings of the National Academy of Sciences, 1993
- The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locusNature, 1988
- Macrocytic-megaloblastic anemia in male NIH Swiss mice following repeated exposure to 1,3-butadieneToxicology and Applied Pharmacology, 1986
- Multiple Organ Carcinogenicity of 1,3-Butadiene in B6C3F1Mice After 60 Weeks of Inhalation ExposureScience, 1985
- T-Lymphocyte–Mediated Granulopoietic FailureNew England Journal of Medicine, 1983
- Glucocorticoid Therapy in the Preleukemic Syndrome (Hemopoietic Dysplasia)Annals of Internal Medicine, 1980
- Human PreleukemiaNew England Journal of Medicine, 1973